Company news
Zhejiang Huakang Pharmaceutical Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Receiving Dividends from Wholly-owned Subsidiary
June 12, 2025
Announcement on Reply to Letter of Supervision and Inquiry from Shanghai Stock Exchange on Information Disclosure of 2024 Annual Report
May 26, 2025
Announcement on Convening the Q1 2025 Performance Briefing
May 19, 2025
Announcement on Completing Implementation of Repurchase and Cancellation of Some Restricted Stocks and Adjusting Conversion Price of "Huakang Convertible Bonds"
May 12, 2025
Announcement on Using Some Idle Raised Funds for Cash Management and Redemption
May 9, 2025
Announcement on Implementation of Repurchase and Cancellation of Partial Restricted Stocks in Equity Incentive
May 6, 2025
Announcement on Acceptance of Application for Issuing Shares to Purchase Assets by Shanghai Stock Exchange
April 29, 2025
Announcement on Change of Sponsor Representative for Continuous Supervision of Initial Public Offering and Listing and Issuance of Convertible Corporate Bonds to Non-specific Objects
April 27, 2025
Announcement on Implementation of Dividend Distribution for 2024
April 16, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
April 14, 2025